TP53 and in situ carcinoma: Muscle-invasive bladder cancer (MIBC) has an unfavorable prognosis (5-year survival <50%) and mainly develops from carcinoma in situ (CIS), a flat-growing, high-grade (HG) lesion characterized by frequent TP53 alterations [2].